Abstract: The present disclosure pertains to pharmaceutically acceptable salts of fospropofol and their use to treat migraine.

Abstract: The present disclosure pertains to pharmaceutically acceptable salts of fospropofol and their use to treat migraine.

Abstract: The present disclosure pertains to pharmaceutically acceptable salts of fospropofol and their use to treat migraine.

Abstract: The present disclosure relates, according to disclosed embodiments, to a system for extracting an organic compound from a natural source, the system comprising a computer processor operational to control the system; a storage vessel configured to store an extraction gas, the storage vessel comprising a storage vessel outlet in electrical communication with the computer processor; a valve in electrical communication with the computer processor, the valve comprising a valve inlet and a valve outlet, wherein the valve inlet connects to the storage vessel outlet; a dynamic extraction vessel; and a spray evaporation loop system configured to receive a solute from the dynamic extraction vessel, the spray evaporation loop system comprising an injection nozzle in electrical communication with the computer processor, the injection nozzle comprising an injection nozzle inlet connected to the first dynamic extraction vessel outlet; and a cyclonic separator in electrical communication with the computer processor.

Abstract: The present disclosure pertains to pharmaceutically acceptable salts of fospropofol and their use to treat migraine.

Abstract: Described herein, inter alia, are processes, methods, and compositions useful for the extraction of natural products from source materials.

Abstract: The present disclosure relates, according to disclosed embodiments, to a system for extracting an organic compound from a natural source, the system comprising a computer processor operational to control the system; a storage vessel configured to store an extraction gas, the storage vessel comprising a storage vessel outlet in electrical communication with the computer processor; a valve in electrical communication with the computer processor, the valve comprising a valve inlet and a valve outlet, wherein the valve inlet connects to the storage vessel outlet; a dynamic extraction vessel; and a spray evaporation loop system configured to receive a solute from the dynamic extraction vessel, the spray evaporation loop system comprising an injection nozzle in electrical communication with the computer processor, the injection nozzle comprising an injection nozzle inlet connected to the first dynamic extraction vessel outlet; and a cyclonic separator in electrical communication with the computer processor.

Abstract: The present disclosure relates, according to disclosed embodiments, to a system for extracting an organic compound from a natural source, the system comprising a computer processor operational to control the system; a storage vessel configured to store an extraction gas, the storage vessel comprising a storage vessel outlet in electrical communication with the computer processor; a valve in electrical communication with the computer processor, the valve comprising a valve inlet and a valve outlet, wherein the valve inlet connects to the storage vessel outlet; a dynamic extraction vessel; and a spray evaporation loop system configured to receive a solute from the dynamic extraction vessel, the spray evaporation loop system comprising an injection nozzle in electrical communication with the computer processor, the injection nozzle comprising an injection nozzle inlet connected to the first dynamic extraction vessel outlet; and a cyclonic separator in electrical communication with the computer processor.

Abstract: The present disclosure relates, according to disclosed embodiments, to a system for extracting an organic compound from a natural source, the system comprising a computer processor operational to control the system; a storage vessel configured to store an extraction gas, the storage vessel comprising a storage vessel outlet in electrical communication with the computer processor; a valve in electrical communication with the computer processor, the valve comprising a valve inlet and a valve outlet, wherein the valve inlet connects to the storage vessel outlet; a dynamic extraction vessel; and a spray evaporation loop system configured to receive a solute from the dynamic extraction vessel, the spray evaporation loop system comprising an injection nozzle in electrical communication with the computer processor, the injection nozzle comprising an injection nozzle inlet connected to the first dynamic extraction vessel outlet; and a cyclonic separator in electrical communication with the computer processor.

Abstract: Epicatechins, Epicatechin Oligomers, or Thiolated Epicatechins are applied (A) directly to a genital wart in the form of a cream, ointment, paste or solution, (B) directly to the genital wart wherein such cream, ointment, paste or solution contains as an additional active ingredient a skin permeabilizing agent, (C) following electrosurgical resection or removal of the genital wart in such form of a cream, ointment, paste or solution, (D) following chemical resection or extirpation of the genital wart in such form, (E) following surgical resection or removal of the genital wart in such form, wherein said Epicatechins, Epicatechin Oligomers, or Thiolated Epicatechins both provide antiviral activity against multiple strains of human pappilomavirus (HPV) and promote healing following resection polymers contained in a vehicle. Disclosed are the compositions, therapeutical kits containing such composition, methods of treatment using such composition, and methods of enhancing the stability of such composition.

Abstract: Methods and materials for modulating (e.g., increasing or decreasing) flavonoid levels in cacao plants are disclosed. For example, nucleic acids encoding flavonoid-modulating polypeptides are disclosed as well as methods for using such nucleic acids to transform plant cells. Also provided are methods for accelerating breeding of Theobroma cacao plants of the porcelana variety with modulated levels of proanthocyanidin, its precursors and it polymers, useful in various medical and skin care products. Also provided are plants having modulated flavonoid levels and plant products produced from plants having modulated flavonoid levels.

Abstract: Described herein, inter alia, are processes, methods, and compositions useful for the extraction of natural products from source materials.

Abstract: Epicatechins, Epicatechin Oligomers, or Thiolated Epicatechins are applied (A) directly to a genital wart in the form of a cream, ointment, paste or solution, (B) directly to the genital wart wherein such cream, ointment, paste or solution contains as an additional active ingredient a skin permeabilizing agent, (C) following electrosurgical resection or removal of the genital wart in such form of a cream, ointment, paste or solution, (D) following chemical resection or extirpation of the genital wart in such form, (E) following surgical resection or removal of the genital wart in such form, wherein said Epicatechins, Epicatechin Oligomers, or Thiolated Epicatechins both provide antiviral activity against multiple strains of human pappilomavirus (HPV) and promote healing following resection polymers contained in a vehicle. Disclosed are the compositions, therapeutical kits containing such composition, methods of treatment using such composition, and methods of enhancing the stability of such composition.

Abstract: Methods and materials for modulating (e.g., increasing or decreasing) flavonoid levels in cacao plants are disclosed. For example, nucleic acids encoding flavonoid-modulating polypeptides are disclosed as well as methods for using such nucleic acids to transform plant cells. Also provided are methods for accelerating breeding of Theobroma cacao plants of the porcelana variety with modulated levels of proanthocyanidin, its precursors and it polymers, useful in various medical and skin care products. Also provided are plants having modulated flavonoid levels and plant products produced from plants having modulated flavonoid levels.

Abstract: Methods and materials for modulating (e.g., increasing or decreasing) flavonoid levels in cacao plants are disclosed. For example, nucleic acids encoding flavonoid-modulating polypeptides are disclosed as well as methods for using such nucleic acids to transform plant cells. Also provided are methods for accelerating breeding of Theobroma cacao plants of the porcelana variety with modulated levels of proanthocyanidin, its precursors and it polymers, useful in various medical and skin care products. Also provided are plants having modulated flavonoid levels and plant products produced from plants having modulated flavonoid levels.

Abstract: Epicatechins, Epicatechin Oligomers, or Thiolated Epicatechins are applied (A) directly to a genital wart in the form of a cream, ointment, paste or solution, (B) directly to the genital wart wherein such cream, ointment, paste or solution contains as an additional active ingredient a skin permeabilizing agent, (C) following electrosurgical resection or removal of the genital wart in such form of a cream, ointment, paste or solution, (D) following chemical resection or extirpation of the genital wart in such form, (E) following surgical resection or removal of the genital wart in such form, wherein said Epicatechins, Epicatechin Oligomers, or Thiolated Epicatechins both provide antiviral activity against multiple strains of human pappilomavirus (HPV) and promote healing following resection polymers contained in a vehicle. Disclosed are the compositions, therapeutical kits containing such composition, methods of treatment using such composition, and methods of enhancing the stability of such composition.

Abstract: Provided herein are methods and compositions for treating a subject who has pulmonary damage or an injury caused by or who is at risk for an injury caused by an anti-vesicant agent. The compositions comprise cacao extracts that include a mixture of epicatechin and one or more epicatechin oligomers and a pharmaceutically acceptable carrier. Also provided are methods for fermenting cacao to enhance epicatechin and antioxidant content.

Abstract: Bioluminescent endoscopy methods and compounds, wherein an anatomical object is examined by means of filling, perfusing, intubating, injecting, or otherwise administering a solution containing a bioluminescent substance or a mixture of luciferin and luciferase which produces bioluminescence, wherein a color or monochrome image of the object is constituted using the images and information based on bioluminescent emitted by the bioluminescent substance. Procedures are demonstrated which allow bioluminescent solutions to be perfused into certain tissue regions, such as but not limited to the common biliary duct, genitourinary tract, gastro-intestinal tract, cardiovascular system and lymphatic system wherein said structures may be conveniently visualized during surgery to avoid damage to these structures. Such images may also be combined with visual light images. Methods of detection of cancer cells using bioluminescence are provided.

Abstract: Bioluminescent endoscopy methods in which bioluminescent generating system components are combined ex vivo immediately prior to injection or infusion into a tissue area of interest to enable bioluminescent viewing of the tissue. The bioluminescent generating system components are combined by simultaneous injection into a Y tube or other in-line mixing chamber receiving fluid inputs from two or more fluid conduits and providing a fluid output to at least one fluid conduit. The mixed components which are the output of such multi lumen mixing system is injected into a hollow viscus organ or otherwise applied to organs and/or tissues of the body.

Abstract: Provided herein are methods and compositions for treating a subject who has pulmonary damage or an injury caused by or who is at risk for an injury caused by an anti-vesicant agent. The compositions comprise cacao extracts that include a mixture of epicatechin and one or more epicatechin oligomers and a pharmaceutically acceptable carrier. Also provided are methods for fermenting cacao to enhance epicatechin and antioxidant content.